Business Description
Next Science Ltd
ISIN : AU0000041329
Description
Next Science Ltd is a medical technology company. It is engaged in the development and commercialization of its proprietary Xbio technology to reduce the impact of biofilm-based infections in human health. Xbio is a non-toxic technology with proven efficacy in eradicating both biofilm based and free-floating bacteria. Its products include Bactisure, SURGX, XEPERIENCE and BLASTX. The company derives revenue from the U.S. and Australia, of which prime revenue is derived from the U.S.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 9.65 | |||||
| Equity-to-Asset | 0.72 | |||||
| Debt-to-Equity | 0.08 | |||||
| Debt-to-EBITDA | -0.07 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 3.75 | |||||
| Beneish M-Score | -1.97 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 80.9 | |||||
| 3-Year EBITDA Growth Rate | -3.1 | |||||
| 3-Year EPS without NRI Growth Rate | -7.4 | |||||
| 3-Year FCF Growth Rate | -4.6 | |||||
| 3-Year Book Growth Rate | -20 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 68.19 | |||||
| 9-Day RSI | 67.85 | |||||
| 14-Day RSI | 65.22 | |||||
| 6-1 Month Momentum % | -5 | |||||
| 12-1 Month Momentum % | -49.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.64 | |||||
| Quick Ratio | 3.45 | |||||
| Cash Ratio | 2.42 | |||||
| Days Inventory | 53.71 | |||||
| Days Sales Outstanding | 41.78 | |||||
| Days Payable | 116.63 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -14.5 | |||||
| Shareholder Yield % | -2.56 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 73.2 | |||||
| Operating Margin % | -77.27 | |||||
| Net Margin % | -73.34 | |||||
| FCF Margin % | -71.87 | |||||
| ROE % | -234.61 | |||||
| ROA % | -115.74 | |||||
| ROIC % | -325.58 | |||||
| ROC (Joel Greenblatt) % | -746.81 | |||||
| ROCE % | -146.6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.33 | |||||
| PB Ratio | 7.12 | |||||
| Price-to-Tangible-Book | 8.7 | |||||
| EV-to-EBIT | -4.92 | |||||
| EV-to-Forward-EBIT | -4.77 | |||||
| EV-to-EBITDA | -5.3 | |||||
| EV-to-Forward-EBITDA | -4.97 | |||||
| EV-to-Revenue | 3.44 | |||||
| EV-to-Forward-Revenue | 2.22 | |||||
| EV-to-FCF | -5.22 | |||||
| Price-to-Net-Current-Asset-Value | 8.7 | |||||
| Price-to-Net-Cash | 21.75 | |||||
| Earnings Yield (Greenblatt) % | -20.32 | |||||
| FCF Yield % | -18.75 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Next Science Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 33.096 | ||
| EPS (TTM) (A$) | -0.104 | ||
| Beta | 2 | ||
| Volatility % | 82.65 | ||
| 14-Day RSI | 65.22 | ||
| 14-Day ATR (A$) | 0.029281 | ||
| 20-Day SMA (A$) | 0.36225 | ||
| 12-1 Month Momentum % | -49.33 | ||
| 52-Week Range (A$) | 0.18 - 0.75 | ||
| Shares Outstanding (Mil) | 291.7 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Next Science Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Next Science Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Next Science Ltd Frequently Asked Questions
What is Next Science Ltd(ASX:NXS)'s stock price today?
The current price of ASX:NXS is A$0.44. The 52 week high of ASX:NXS is A$0.75 and 52 week low is A$0.18.
When is next earnings date of Next Science Ltd(ASX:NXS)?
The next earnings date of Next Science Ltd(ASX:NXS) is .
Does Next Science Ltd(ASX:NXS) pay dividends? If so, how much?
Next Science Ltd(ASX:NXS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers